Myonex Acquires Creapharm's Pharmaceutical Services Business

Myonex Acquires Hubertus Apotheke Clinical Trial and Packaging Business

October 5, 2022

Healthcare Services

Myonex has completed the acquisition of the clinical trial and packaging business of Hubertus Apotheke in Berlin, Germany. The deal creates Myonex GmbH, expanding Myonex’s EU footprint and strengthening its packaging, labeling and sourcing capabilities to support clinical trials across the European Union.

Myonex Acquires SaveWay Compounding Pharmacy

April 10, 2024

Healthcare Services

Myonex has completed the acquisition of SaveWay Compounding Pharmacy, a Newark, Delaware-based compounding pharmacy, to expand its direct-to-patient and home healthcare capabilities for clinical trials across the United States. The purchase enhances Myonex's clinical trial supply offerings—adding compounding, drug sourcing and dispensing capabilities to support decentralized and hybrid trials nationwide.

Adragos Pharma Acquires Baccinex

February 6, 2025

Pharmaceuticals

Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.

Noramco Acquires Cambrex Drug Product Business Unit (Halo Pharmaceuticals)

November 2, 2023

Pharmaceuticals

Noramco has completed the acquisition of the Cambrex Drug Product Business Unit (previously Halo Pharmaceuticals), adding drug product formulation development, clinical and commercial manufacturing, and packaging capabilities from sites in Mirabel, Québec and Whippany, New Jersey. The purchase expands Noramco's service offering beyond APIs, brings nearly 400 employees into the Noramco group, and represents Cambrex's strategic divestiture to focus on its drug substance and analytical testing businesses.

AmerisourceBergen Acquires PharmaLex from AUCTUS in €1.28bn Transaction

December 31, 2022

Healthcare Services

AmerisourceBergen Corporation acquired a majority stake in PharmaLex from funds advised by AUCTUS Capital Partners AG in a transaction that closed at year-end 2022 for approximately EUR 1.28 billion. PharmaLex, a Germany-headquartered provider of regulatory, clinical development and pharmacovigilance services to the life sciences industry, was grown under AUCTUS through a buy-and-build program of 38 add-ons and will expand AmerisourceBergen's global pharmaceutical solutions.

Alcami Acquires TriPharm Services to Expand Sterile Fill‑Finish Capacity

January 17, 2020

Pharmaceuticals

Alcami Corporation has acquired TriPharm Services, a new sterile fill‑finish manufacturing center near Research Triangle Park, North Carolina. Funds affiliated with Alcami majority owner Madison Dearborn Partners made an additional equity investment to support Alcami's growth plan, while Ampersand Capital Partners rolled a portion of its TriPharm ownership into Alcami.